Niagen Bioscience, Inc. — Director's Dealing 2013

Apr 23, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC.OB)
CIK: 0001386570
Period of Report: 2013-04-19

Reporting Person: Brauser Michael (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-04-19	Common Stock	X	357142	$0.21	Acquired	2217854	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-04-19	Warrants to Purchase Common Stock	$0.21	X	357142	Disposed	2013-05-20	Common Stock (357142)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4494926	Direct

Footnotes

F1: Indirect beneficial ownership includes: (i) 314,285 Shares held by Grander Holdings, Inc. 401K Profit Sharing Plan of which the Reporting Person is a trustee; (ii) 342,857 Shares held by the Brauser 2010 GRAT of which the Reporting Person is a trustee; (iii) 846,428 Shares held by BMB Holdings, LLLP of which the Reporting Person is the manager of its general partner; and (iv) 714,284 Shares held by Betsy Brauser Third Amended Trust Agreement beneficially owned by the Reporting Person's spouse which are disclaimed by him. Betsy Brauser Third Amended Trust Agreement is the entity that acquired 357,142 shares reported on this form by exercising Warrants.

F2: Indirect beneficial ownership includes: (i) 314,285 Warrants held by Grander Holdings, Inc. 401K Profit Sharing Plan of which the Reporting Person is a trustee; (ii) 342,857 Warrants held by the Brauser 2010 GRAT of which the Reporting Person is a trustee; and (iii) 846,428 Warrants held by BMB Holdings, LLLP of which the Reporting Person is the manager of its general partner.